Company news
Gossamer Bio, Inc. (NASDAQ:GOSS) news
Gossamer Bio, Inc. news releases on 6ix. Latest, Jan 23, 2020: Gossamer Bio Announces Data Presentation at the 2020 Crohn’s & Colitis Congress
Press releases — page 3
Gossamer Bio Announces Data Presentation at the 2020 Crohn’s & Colitis Congress
January 22, 2020
Gossamer Bio Announces Participation in the Guggenheim Healthcare Talks Neuro/Immunology Day
November 13, 2019
Gossamer Bio Announces Third Quarter 2019 Financial Results
November 11, 2019
Gossamer Bio Announces Clinical Trial Collaboration Agreement With Merck to Evaluate GB1275 in Combination With KEYTRUDA® (Pembrolizumab) in Selected Advanced Solid Tumors
November 11, 2019
Gossamer Bio Announces Data Presentations at the American Heart Association Scientific Sessions 2019
November 10, 2019
Gossamer Bio Announces Data Presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting 2019
November 7, 2019
Gossamer Bio Announces Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting
November 6, 2019
Gossamer Bio to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 12, 2019
November 4, 2019
Gossamer Bio Announces Participation in the 2019 Cantor Global Healthcare Conference
September 24, 2019
Gossamer Bio Announces the Departure of Dr. Otello Stampacchia from its Board of Directors
September 12, 2019